Case Study: Validating Biomarkers in Immunotherapy Trials
Case Study: Validating Biomarkers in Immunotherapy Trials Real-World Case Study on Biomarker Validation in Immunotherapy Trials Introduction to Biomarkers in Immuno-Oncology Immunotherapy has revolutionized cancer treatment, but its success hinges on identifying patients most likely to benefit. Biomarkers such as PD-L1 expression, tumor mutational burden (TMB), and microsatellite instability (MSI) are used to predict response…
Read More “Case Study: Validating Biomarkers in Immunotherapy Trials” »